Developing CRISPR genome therapy for Alzheimer's disease
Description: Can modifying a gene variation of APOE reduce Alzheimer’s risk?
Funder: Alzheimer's Association
Funding type: research
Funder scheme: NIAP
Start date: 2024-01-01
Investigator: Claire Clelland
Institution: University of California, San Francisco
Funded outputs count: 1
Funder award ID: NIAP24-1272942
OpenAlex ID: G2673466125